Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivity Journal Article


Authors: Chien, Y.; Scuoppo, C.; Wang, X.; Fang, X.; Balgley, B.; Bolden, J. E.; Premsrirut, P.; Luo, W.; Chicas, A.; Lee, C. S.; Kogan, S. C.; Lowe, S. W.
Article Title: Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivity
Abstract: Cellular senescence acts as a potent barrier to tumorigenesis and contributes to the anti-tumor activity of certain chemotherapeutic agents. Senescent cells undergo a stable cell cycle arrest controlled by RB and p53 and, in addition, display a senescence-associated secretory phenotype (SASP) involving the production of factors that reinforce the senescence arrest, alter the microenvironment, and trigger immune surveillance of the senescent cells. Through a proteomics analysis of senescent chromatin, we identified the nuclear factor-κB (NF-κB) subunit p65 as a major transcription factor that accumulates on chromatin of senescent cells. We found that NF-κB acts as a master regulator of the SASP, influencing the expression of more genes than RB and p53 combined. In cultured fibroblasts, NF-κB suppression causes escape from immune recognition by natural killer (NK) cells and cooperates with p53 inactivation to bypass senescence. In a mouse lymphoma model, NF-κB inhibition bypasses treatment-induced senescence, producing drug resistance, early relapse, and reduced survival. Our results demonstrate that NF-κB controls both cell-autonomous and non-cell-autonomous aspects of the senescence program and identify a tumor-suppressive function of NF-κB that contributes to the outcome of cancer therapy. © 2011 by Cold Spring Harbor Laboratory Press.
Keywords: controlled study; human cell; nonhuman; mouse; phenotype; animals; mice; cell survival; gene expression; cell line; animal experiment; animal model; rna, small interfering; cyclophosphamide; immunoglobulin enhancer binding protein; transcription factor rela; drug resistance; chemosensitivity; cell line, tumor; protein p53; gene expression regulation, neoplastic; chromatin; lymphoma; fibroblast; protein secretion; tumor suppressor protein p53; natural killer cell; senescence; doxycycline; tetracycline; cell aging; short hairpin rna; synaptotagmin i; chemoresistance; protein synthesis inhibitors; sasp; senescence associated secretory phenotype; nf-?b
Journal Title: Genes and Development
Volume: 25
Issue: 20
ISSN: 0890-9369
Publisher: Cold Spring Harbor Laboratory Press  
Date Published: 2011-10-15
Start Page: 2125
End Page: 2136
Language: English
DOI: 10.1101/gad.17276711
PROVIDER: scopus
PMCID: PMC3205583
PUBMED: 21979375
DOI/URL:
Notes: --- - "Cited By (since 1996): 2" - "Export Date: 9 December 2011" - "CODEN: GEDEE" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Scott W Lowe
    249 Lowe